Answer
ApoE4 status determines eligibility and helps assess ARIA and bleeding risk. MRI identifies existing risks and monitors for ARIA.
Sources for this answer
- Kisunla 350 mg concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.